Publications by authors named "Celine Ferlay"

Claim this Profile
E
Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Christian Carrie, Virginie Kieffer, Dominique Figarella-Branger, Julien Masliah-Planchon, Stéphanie Bolle, Céline Ferlay

Int J Radiat Oncol Biol Phys· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial.
Sylvie Negrier, Nathalie Rioux-Leclercq, Céline Ferlay, Marine Gross-Goupil, Gwenaëlle Gravis

Eur J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, Céline Ferlay

Lancet Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgery.
Patrice Peyrat, Ellen Blanc, Stéphanie Guillermet, Yao Chen, Céline Ferlay

J Surg Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Gaëlle Fossard, Céline Ferlay, Emmanuelle Nicolas-Virelizier, Philippe Rey, François Ducray

Eur J Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Christian Carrie, Ali Hasbini, Guy de Laroche, Pierre Richaud, Stéphane Guerif, Céline Ferlay

Lancet Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases.
Christine Chevreau, Alain Ravaud, Bernard Escudier, Eric Amela, Remy Delva, Celine Ferlay

Clin Genitourin Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients.
Hervé Ghesquières, Aspasia Stamatoullas, Olivier Casasnovas, Franck Morschhauser, Emmanuel Gyan, Céline Ferlay

Leuk Lymphoma· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients.
Jérôme Fayette, Nathalie Bonnin, Céline Ferlay, Benjamin Lallemant, Antoine Ramade

Anticancer Drugs· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study.
Olivier Bylicki, Céline Ferlay, Christos Chouaid, Armelle Lavolé, Fabrice Barlési

J Thorac Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.
Marc Gigante, Guorong Li, Celine Ferlay, David Perol, Ellen Blanc

Anticancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial.
Sylvie Négrier, Gwenaëlle Gravis, David Pérol, Christine Chevreau, Rémy Delva, Céline Ferlay

Lancet Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.
Sawyna Provencher, Céline Ferlay, Khaoula Alaoui-Slimani, Alain Devidas, Stephane Lepretre

Hematol Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
Stéphane Ducassou, Céline Ferlay, Christophe Bergeron, Sandrine Girard, Geneviève Laureys

Br J Haematol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer.
Philippe A Cassier, Isabelle Ray-Coquard, Marie-Pierre Sunyach, Laurence Lancry, Jean-Paul Guastalla, Céline Ferlay

Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication.
Hervé Ghesquières, Céline Ferlay, Catherine Sebban, Catherine Chassagne, Liana Carausu

Hematol Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients.
Romuald Le Scodan, Pascal Pommier, Jean Michel Ardiet, Xavier Montbarbon, Claude Malet, Céline Ferlay

Int J Radiat Oncol Biol Phys· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis